文献速递白血病淋巴瘤

早期慢性淋巴细胞白血病患者中白血病细胞增殖与疾病进展的关系

Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia.
PubMed 文献 · Leukemia · 2017-01-24

在97例新诊断的Rai 0-II期慢性淋巴细胞白血病(CLL)患者中开展盲法前瞻性研究,采用体内2H2O标记测定CLL细胞出生率。中位随访4.0年,33例(34%)按NCI标准需治疗;高出生率见于44%受试者,与较短的无治疗生存期(TFS)、未突变IGHV状态及ZAP70和CD38表达显著相关。多变量模型中仅CLL细胞出生率和IGHV突变状态入选,高出生率风险比3.51(P=0.002),未突变IGHV风险比4.93(P<0.001)。

要点

  • 早期CLL中CLL细胞出生率升高是疾病进展和更早治疗的强预测因子。
  • 高出生率见于44%受试者,与较短TFS、未突变IGHV及ZAP70、CD38表达显著相关。
  • 多变量中仅出生率和IGHV突变状态入选,高出生率HR 3.51,未突变IGHV HR 4.93。

核心结论

  • 早期CLL中CLL细胞出生率升高是疾病进展和更早治疗的强预测因子。
  • 高出生率与较短TFS的关联在IGHV突变和未突变受试者中均可见,两标志物联合比任一单独指标更好地预测TFS。

研究设计与样本

  • 盲法前瞻性研究,纳入97例新诊断的Rai 0-II期CLL患者,采用体内2H2O标记测定CLL细胞出生率。

主要发现

  • 出生率范围为每天0.07%至1.31%新细胞。
  • 中位随访4.0年,33例(34%)按NCI标准需要治疗。
  • 高出生率见于44%受试者,与较短TFS、未突变IGHV状态及ZAP70和CD38表达显著相关。
  • 多变量建模考虑年龄、性别、Rai分期、ZAP70或CD38表达、IGHV突变状态和FISH细胞遗传学,仅CLL细胞出生率和IGHV突变状态符合入选标准。
  • 高出生率风险比3.51(P=0.002),未突变IGHV风险比4.93(P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The clinical course of patients with recently diagnosed early stage chronic lymphocytic leukemia (CLL) is highly variable. We examined the relationship between CLL-cell birth rate and treatment-free survival (TFS) in 97 patients with recently diagnosed, Rai stage 0-II CLL in a blinded, prospective study, using in vivo 2H2O labeling. Birth rates ranged from 0.07 to 1.31% new cells per day. With median follow-up of 4.0 years, 33 subjects (34%) required treatment by NCI criteria. High-birth rate was observed in 44% of subjects and was significantly associated with shorter TFS, unmutated IGHV status and expression of ZAP70 and of CD38. In multivariable modeling considering age, gender, Rai stage, expression of ZAP70 or CD38, IGHV mutation status and FISH cytogenetics, only CLL-cell birth rate and IGHV mutation status met criteria for inclusion. Hazard ratios were 3.51 (P=0.002) for high-birth rate and 4.93 (P<0.001) for unmutated IGHV. The association between elevated birth rate and shorter TFS was observed in subjects with either mutated or unmutated IGHVs, and the use of both markers was a better predictor of TFS than either parameter alone. Thus, an increased CLL birth rate in early stage disease is a strong predictor of disease progression and earlier treatment.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Murphy EJ, Neuberg DS, Rassenti LZ, et al. Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia. Leukemia. 2017. PMID: 28115735. doi:10.1038/leu.2017.34

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。